SPIOLTO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for in Australia - English - Department of Health (Therapeutic Goods Administration)

spiolto respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for in

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - spiolto respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

STRIVERDI RESPIMAT- olodaterol respimat inhalation spray spray, metered United States - English - NLM (National Library of Medicine)

striverdi respimat- olodaterol respimat inhalation spray spray, metered

boehringer ingelheim pharmaceuticals, inc. - olodaterol hydrochloride (unii: 65r445w3v9) (olodaterol - unii:vd2ysn1afd) - olodaterol 2.5 ug - striverdi respimat is a long-acting beta2 -agonist indicated for long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema. striverdi respimat is not indicated to treat acute deteriorations of copd [see warnings and precautions (5.2) ]. striverdi respimat is not indicated to treat asthma. the safety and effectiveness of striverdi respimat in asthma have not been established. use of a laba, including striverdi respimat, without an inhaled corticosteroid is contraindicated in patients with asthma [see warnings and precautions (5.1) ]. striverdi respimat is not indicated for the treatment of asthma. risk summary there are no adequate and well-controlled clinical studies with striverdi respimat in pregnant women to inform of drug-associated risk of adverse pregnancy-related outcomes. there are clinical considerations with the use of striverdi respimat in pregnant women [see clinica

SPIOLTO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator) Australia - English - Department of Health (Therapeutic Goods Administration)

spiolto respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator)

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - spiolto respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Spiolto Respimat New Zealand - English - Medsafe (Medicines Safety Authority)

spiolto respimat

boehringer ingelheim (nz) limited - olodaterol hydrochloride 0.0248%{relative} equivalent to to olodaterol 2.5mcg per actuation; tiotropium bromide monohydrate 0.0283%{relative} equivalent to to tiotropium 2.5mcg per actuation - solution for inhalation - 2.5mcg/2.5mcg - active: olodaterol hydrochloride 0.0248%{relative} equivalent to to olodaterol 2.5mcg per actuation tiotropium bromide monohydrate 0.0283%{relative} equivalent to to tiotropium 2.5mcg per actuation excipient: benzalkonium chloride disodium edetate hydrochloric acid purified water - spiolto respimat is indicated for the long term, once daily maintenance treatment in patients with copd (including chronic bronchitis and emphysema), to reduce airflow obstruction, to improve quality of life, and to reduce associated dyspnoea.

YANIMO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inh Australia - English - Department of Health (Therapeutic Goods Administration)

yanimo respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inh

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - yanimo respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

STRIVERDI RESPIMAT olodaterol (as hydrochloride) 2.5 microgram/actuation solution for inhalation cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

striverdi respimat olodaterol (as hydrochloride) 2.5 microgram/actuation solution for inhalation cartridge

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.7 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: disodium edetate; citric acid; purified water; benzalkonium chloride - striverdi respimat is a long-acting beta2-agonist indicated for once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd).

STIOLTO RESPIMAT- tiotropium bromide and olodaterol spray, metered United States - English - NLM (National Library of Medicine)

stiolto respimat- tiotropium bromide and olodaterol spray, metered

boehringer ingelheim pharmaceuticals inc. - tiotropium bromide monohydrate (unii: l64sxo195n) (tiotropium - unii:0eb439235f), olodaterol hydrochloride (unii: 65r445w3v9) (olodaterol - unii:vd2ysn1afd) - tiotropium 3.124 ug - stiolto respimat is a combination of tiotropium and olodaterol indicated for long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema. important limitations of use - stiolto respimat is not indicated to treat acute deteriorations of copd [see warnings and precautions (5.2)]. - stiolto respimat is not indicated to treat asthma. the safety and effectiveness of stiolto respimat in asthma have not been established. use of a laba, including stiolto respimat, without an inhaled corticosteroid is contraindicated in patients with asthma [see warnings and precautions (5.1)] . stiolto respimat is not indicated for the treatment of asthma. stiolto respimat is contraindicated in patients with a hypersensitivity to tiotropium, ipratropium, olodaterol, or any component of this product [see warnings and precautions (5.4)] . in clinical trials and postmarketing experience with tiotropium, immediate hypersensitivity reactions, inc

Striverdi Respimat Solution for Inhalation 2.5 microgram actuation Singapore - English - HSA (Health Sciences Authority)

striverdi respimat solution for inhalation 2.5 microgram actuation

boehringer ingelheim singapore pte. ltd. - olodaterol hydrochloride 2.7 mcg eqv olodaterol - solution - 2.5 mcg/actuation - olodaterol hydrochloride 2.7 mcg eqv olodaterol 2.5 mcg/actuation

Striverdi Respimat 2.5 µg inhal. sol. cartr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

striverdi respimat 2.5 µg inhal. sol. cartr.

boehringer ingelheim international gmbh - olodaterol hydrochloride 0,0027 mg - eq. olodaterol 0,0025 mg - inhalation solution - 2,5 µg - olodaterol hydrochloride 2.5 µg - olodaterol

STRIVERDI RESPIMAT SOLUTION Canada - English - Health Canada

striverdi respimat solution

boehringer ingelheim (canada) ltd ltee - olodaterol (olodaterol hydrochloride) - solution - 2.5mcg - olodaterol (olodaterol hydrochloride) 2.5mcg - selective beta 2-adrenergic agonists